SCHEMBL6170000

SCHEMBL6170000

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)C(C)c2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
ALDH1A1 P00352 7/20 0.51
MAPT P10636 5/20 0.51
RAB9A P51151 4/20 0.51
NPC1 O15118 2/20 0.51
PKM P14618 1/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
MEN1 O00255 3/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
GAA P10253 2/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 2/20 0.50
KDM4E B2RXH2 1/20 0.50
PTGER4 P35408 1/20 0.48
MAPK1 P28482 1/20 0.45
CYP1A2 P05177 1/20 0.44
TP53 P04637 1/20 0.44
GALR2 O43603 1/20 0.43
MITF O75030 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170341 0.84 KMT2A (0.59) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL8129523 0.84 ALDH1A1 (0.58) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6170252 0.83 KMT2A (0.60) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6168979 0.83 KMT2A (0.57) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6169030 0.82 KMT2A (0.52) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6172633 0.82 KMT2A (0.49) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6169048 0.81 PKM (0.60) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL6169182 0.81 KMT2A (0.81) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL8890463 0.80 KMT2A (0.76) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL25999054 0.80 KMT2A (0.58) KMT2AALDH1A1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed